NCT02161016View on ClinicalTrials.gov

A Clinical Study of Outcomes in Foot and Ankle Bone Grafting Using map3® Cellular Allogeneic Bone Graft

PHASE4TerminatedINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

January 31, 2015

Study Completion Date

January 31, 2015

Conditions
Foot Deformities, AcquiredDisorder of Joint of FootFracture of FootDeformity of Bone
Interventions
DEVICE

map3

Patients will receive map3® Cellular Allogeneic Bone Graft containing donor matched stem cells.

Trial Locations (1)

11576

Saint Francis Hospital, Roslyn

Sponsors

Lead Sponsor

RTI Surgical
All Listed Sponsors
lead

RTI Surgical

INDUSTRY